Anti-PD-1 therapy using cemiplimab for advanced cutaneous squamous cell carcinoma in HIV patient: A case report

Abdurahman Alloghbi; James Ninia; Bayan Alshare; Jeffrey Hotaling; Syed Raza; Ammar Sukari

doi:10.1002/ccr3.5228

Anti-PD-1 therapy using cemiplimab for advanced cutaneous squamous cell carcinoma in HIV patient: A case report

Clin Case Rep. 2021 Dec 15;9(12):e05228. doi: 10.1002/ccr3.5228. eCollection 2021 Dec.

Authors

Abdurahman Alloghbi¹, James Ninia², Bayan Alshare¹, Jeffrey Hotaling³, Syed Raza³, Ammar Sukari¹

Affiliations

¹ Department of Oncology Karmanos Cancer Institute Wayne State University Detroit Michigan USA.
² School of Medicine Wayne State University Detroit Michigan USA.
³ Department of Surgical Oncology Karmanos Cancer Institute Detroit Michigan USA.

Abstract

This is a case of a 60-year-old man living with HIV who presented with advanced cutaneous squamous cell carcinoma. After workup, medical and surgical treatment, and disease recurrence, he achieved a complete response with no unexpected toxicities after immunotherapy with cemiplimab.

Keywords: advanced cutaneous squamous cell carcinoma; cemiplimab; immunotherapy; skin cancer; squamous cell carcinoma.

Publication types

Case Reports